Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
MXIM Stock Summary
In the News
5 Stocks to Buy as Microchip Industry Continues to Thrive
Growing demand for microchips amid supply crunch has been helping companies like Texas Instruments (TXN) and Maxim Integrated Products (MXIM).
Why Are Maxim Integrated's Shares Trading Higher Today?
The China State Administration for Market Regulation issued an antitrust clearance for chipmaker Analog Devices, Inc's (NASDAQ: ADI) proposed acquisition of peer Maxim Integrated Products, Inc. (NASDAQ: MXIM). It is a big win amid a rigorous global regulatory environment that saw roadblocks to NVIDIA Corp's (NASDAQ: NVDA) Arm deal.
NBXG: New Fund Provides Some Interesting Exposure
NBXG: New Fund Provides Some Interesting Exposure
Jeld-Wen Holding Inc Ranked Among Today's Top Buys
The Dow Jones, S&P 500, and Nasdaq were all lower, with the Nasdaq taking the brunt of it down 1.3% in early trading. Make the most of this market with today's Top Buys from Q.ai's artificial intelligence.
Supply Crunch Puts Microchips in Focus: 5 Stocks to Buy
Growing demand for microchips is driving sales, which is helping companies like Maxim Integrated Products (MXIM) and Texas Instruments Incorporated (TXN).
5 Solid Stocks to Buy on a Booming Semiconductor Market
Semiconductor sales are surge on increased demand which is helping stocks like TXN, SMTC, MXIM, NXPI and ADI.
Maxim Integrated Products (MXIM) Surpasses Q4 Earnings and Revenue Estimates
Maxim (MXIM) delivered earnings and revenue surprises of 5.81% and 4.68%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Maxim Integrated Teams with Xailient to Provide World's Fastest and Lowest-Power IoT Face Detection
SAN JOSE, Calif., July 27, 2021 /PRNewswire/ -- Maxim Integrated Products, Inc. (NASDAQ: MXIM) and Xailient Inc., a company focused on artificial intelligence (AI) for the edge, today announced that Maxim Integrated's MAX78000 ultra-low power neural-network microcontroller detects and localizes faces in video and images using Xailient's proprietary Detectum™ neural network.
Elliptic Labs and Maxim Integrated Offer Low-Power Touchless Sensing Solutions to PC and Smart Speaker/TV Developers
OSLO, Norway--(BUSINESS WIRE)-- #AI--Elliptic Labs announces that it certified the operation of its AI Virtual Smart Sensor Platform with the MAX98396 smart audio amplifier from Maxim.
Reviva Pharma Stock Is Trading Higher After Maxim Initiated With Buy, Target Price Of $10
Reviva Pharmaceuticals Holdings Inc (NASDAQ: RVPH) is trading higher with around 60k in session volume. Maxim initiated coverage of Reviva with a Buy rating and $10 price target, equivalent to an upside of around 140%.
MXIM Financial details
MXIM Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2021-06-26
Metric | History | 2017-06-24 | 2018-06-30 | 2019-06-29 | 2020-06-27 | 2021-06-26 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 7.97 | 8.68 | 8.3 | 8.06 | 9.72 | |
Net income per share | 1.98 | 1.64 | 2.97 | 2.41 | 3.05 | |
Operating cash flow per share | 2.69 | 2.87 | 3.14 | 2.94 | 3.41 | |
Free cash flow per share | 2.51 | 2.64 | 2.84 | 2.7 | 3.17 | |
Cash per share | 9.53 | 9.19 | 6.81 | 5.93 | 8.46 | |
Book value per share | 7.65 | 6.76 | 6.62 | 6.09 | 8.92 | |
Tangible book value per share | 5.63 | 4.62 | 4.51 | 3.7 | 6.6 | |
Share holders equity per share | 7.65 | 6.76 | 6.62 | 6.09 | 8.92 | |
Interest debt per share | 5.18 | 5.39 | 3.72 | 3.79 | 3.81 | |
Market cap | 13.22B | 16.76B | 16.68B | 16.1B | 27.81B | |
Enterprise value | 12.47B | 16.7B | 15.91B | 15.52B | 26.51B | |
P/E ratio | 23.13 | 35.86 | 20.15 | 24.6 | 33.61 | |
Price to sales ratio | 5.76 | 6.76 | 7.21 | 7.35 | 10.56 | |
POCF ratio | 17.09 | 20.45 | 19.04 | 20.11 | 30.09 | |
PFCF ratio | 18.31 | 22.23 | 21.03 | 21.95 | 32.36 | |
P/B Ratio | 6 | 8.68 | 9.04 | 9.72 | 11.51 | |
PTB ratio | 6 | 8.68 | 9.04 | 9.72 | 11.51 | |
EV to sales | 5.43 | 6.74 | 6.88 | 7.08 | 10.07 | |
Enterprise value over EBITDA | 14.77 | 16.38 | 17.51 | 18.87 | 24.97 | |
EV to operating cash flow | 16.11 | 20.38 | 18.17 | 19.38 | 28.68 | |
EV to free cash flow | 17.26 | 22.16 | 20.06 | 21.15 | 30.85 | |
Earnings yield | 0.04 | 0.03 | 0.05 | 0.04 | 0.03 | |
Free cash flow yield | 0.05 | 0.04 | 0.05 | 0.05 | 0.03 | |
Debt to equity | 0.68 | 0.77 | 0.54 | 0.6 | 0.41 | |
Debt to assets | 0.33 | 0.33 | 0.27 | 0.27 | 0.22 | |
Net debt to EBITDA | -0.9 | -0.05 | -0.84 | -0.71 | -1.22 | |
Current ratio | 11.85 | 4.03 | 6.84 | 5.11 | 5.05 | |
Interest coverage | 0 | 16.92 | 17.16 | 19.17 | 26.84 | |
Income quality | 1.35 | 1.75 | 1.06 | 1.22 | 1.12 | |
Dividend Yield | 0.03 | 0.03 | 0.03 | 0.03 | 0 | |
Payout ratio | 0.65 | 0.94 | 0.61 | 0.79 | 0.15 | |
Sales general and administrative to revenue | 0.13 | 0.13 | 0.13 | 0.14 | 0 | |
Research and developement to revenue | 0.2 | 0.18 | 0.19 | 0.2 | 0.17 | |
Intangibles to total assets | 0.13 | 0.14 | 0.16 | 0.18 | 0.14 | |
Capex to operating cash flow | -0.07 | -0.08 | -0.09 | -0.08 | -0.07 | |
Capex to revenue | -0.02 | -0.03 | -0.04 | -0.03 | -0.02 | |
Capex to depreciation | -0.31 | -0.45 | -0.75 | -0.62 | -0.67 | |
Stock based compensation to revenue | 0.03 | 0.03 | 0.04 | 0.04 | 0.04 | |
Graham number | 18.48 | 15.77 | 21.03 | 18.16 | 24.76 | |
ROIC | 0.16 | 0.14 | 0.29 | 0.25 | 0.25 | |
Return on tangible assets | 0.14 | 0.12 | 0.26 | 0.22 | 0.21 | |
Graham Net | 2.41 | 1.6 | 1.41 | 0.28 | 2.94 | |
Working capital | 3.03B | 2.41B | 2.17B | 1.86B | 2.58B | |
Tangible asset value | 1.62B | 1.32B | 1.26B | 1.01B | 1.79B | |
Net current asset value | 938.06M | 689.79M | 640.79M | 345.98M | 1.11B | |
Invested capital | 0.68 | 0.77 | 0.54 | 0.6 | 0.41 | |
Average receivables | 256.49M | 268.26M | 320.04M | 382.4M | 531.8M | |
Average payables | 79.95M | 84.97M | 88.45M | 88.16M | 110.85M | |
Average inventory | 237.59M | 264.82M | 264.45M | 253.07M | 248.52M | |
Days sales outstanding | 40.78 | 41.22 | 56.78 | 67.42 | 91.35 | |
Days payables outstanding | 33.26 | 39.57 | 37.82 | 44.25 | 54.28 | |
Days of inventory on hand | 106.28 | 120.7 | 110.56 | 124.9 | 99.36 | |
Receivables turnover | 8.95 | 8.86 | 6.43 | 5.41 | 4 | |
Payables turnover | 10.97 | 9.22 | 9.65 | 8.25 | 6.72 | |
Inventory turnover | 3.43 | 3.02 | 3.3 | 2.92 | 3.67 | |
ROE | 0.26 | 0.24 | 0.45 | 0.39 | 0.34 | |
Capex per share | -0.18 | -0.23 | -0.3 | -0.25 | -0.24 |
Quarterly Fundamentals Overview
Last date of statement is 2021-06-26 for Q2
Metric | History | 2020-06-27 | 2020-09-26 | 2020-12-26 | 2021-03-27 | 2021-06-26 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.03 | 2.32 | 2.35 | 2.48 | 2.69 | |
Net income per share | 0.77 | 0.64 | 0.69 | 0.82 | 0.95 | |
Operating cash flow per share | 0.79 | 0.61 | 0.79 | 1.01 | 1.04 | |
Free cash flow per share | 0.73 | 0.56 | 0.73 | 0.95 | 0.97 | |
Cash per share | 6.01 | 6.04 | 6.77 | 7.59 | 8.55 | |
Book value per share | 6.17 | 6.41 | 7.22 | 8.02 | 9.02 | |
Tangible book value per share | 3.75 | 3.99 | 4.4 | 5.66 | 6.67 | |
Share holders equity per share | 6.17 | 6.41 | 7.22 | 8.02 | 9.02 | |
Interest debt per share | 3.7 | 3.73 | 3.73 | 3.71 | 3.72 | |
Market cap | 15.9B | 17.49B | 23.1B | 24.95B | 27.5B | |
Enterprise value | 15.31B | 16.88B | 22.3B | 23.91B | 26.21B | |
P/E ratio | 19.17 | 25.79 | 31.4 | 28.35 | 27.1 | |
Price to sales ratio | 29.15 | 28.23 | 36.77 | 37.52 | 38.2 | |
POCF ratio | 74.88 | 107.6 | 109.75 | 91.92 | 98.29 | |
PFCF ratio | 80.85 | 116.74 | 119.08 | 97.77 | 105.65 | |
P/B Ratio | 9.59 | 10.22 | 11.99 | 11.61 | 11.38 | |
PTB ratio | 9.59 | 10.22 | 11.99 | 11.61 | 11.38 | |
EV to sales | 28.08 | 27.26 | 35.49 | 35.96 | 36.4 | |
Enterprise value over EBITDA | 74.38 | 77.24 | 95.05 | 87.97 | 87.01 | |
EV to operating cash flow | 72.12 | 103.9 | 105.94 | 88.1 | 93.66 | |
EV to free cash flow | 77.87 | 112.73 | 114.94 | 93.7 | 100.67 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Free cash flow yield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |
Debt to equity | 0.6 | 0.58 | 0.52 | 0.46 | 0.41 | |
Debt to assets | 0.27 | 0.27 | 0.26 | 0.24 | 0.22 | |
Net debt to EBITDA | -2.84 | -2.75 | -3.42 | -3.82 | -4.3 | |
Current ratio | 5.11 | 5.28 | 5.67 | 5.38 | 5.05 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | 1.02 | 0.96 | 1.14 | 1.23 | 1.1 | |
Dividend Yield | 0.01 | 0.01 | 0 | 0 | 0 | |
Payout ratio | 0.62 | 0.76 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.13 | 0 | 0.13 | 0 | 0 | |
Research and developement to revenue | 0.2 | 0.19 | 0.18 | 0.16 | 0.16 | |
Intangibles to total assets | 0.18 | 0.18 | 0.17 | 0.15 | 0.14 | |
Capex to operating cash flow | -0.07 | -0.08 | -0.08 | -0.06 | -0.07 | |
Capex to revenue | -0.03 | -0.02 | -0.03 | -0.02 | -0.03 | |
Capex to depreciation | -0.43 | -0.53 | -0.68 | -0.66 | -0.83 | |
Stock based compensation to revenue | 0.04 | 0.06 | 0.05 | 0.03 | 0.03 | |
Graham number | 10.35 | 9.57 | 10.58 | 12.18 | 13.86 | |
ROIC | 0.08 | 0.07 | 0 | 0.07 | 0.08 | |
Return on tangible assets | 0.07 | 0.06 | 0.06 | 0.06 | 0.07 | |
Graham Net | 0.28 | 0.52 | 1.29 | 2.09 | 2.98 | |
Working capital | 1.86B | 1.91B | 2.13B | 2.34B | 2.58B | |
Tangible asset value | 1.01B | 1.07B | 1.17B | 1.52B | 1.79B | |
Net current asset value | 345.98M | 414.46M | 632.28M | 851.74M | 1.11B | |
Invested capital | 0.6 | 0.58 | 0.52 | 0.46 | 0.41 | |
Average receivables | 391.53M | 427.08M | 467.57M | 528.41M | 614.94M | |
Average payables | 87.75M | 89.41M | 91.9M | 99.61M | 115.99M | |
Average inventory | 240.16M | 262.65M | 263.57M | 251.91M | 239.88M | |
Days sales outstanding | 66.8 | 65.3 | 69.59 | 77.28 | 82.37 | |
Days payables outstanding | 45.24 | 38.62 | 41.19 | 41.43 | 49.5 | |
Days of inventory on hand | 127.68 | 118.16 | 111.07 | 98.18 | 90.6 | |
Receivables turnover | 1.35 | 1.38 | 1.29 | 1.16 | 1.09 | |
Payables turnover | 1.99 | 2.33 | 2.19 | 2.17 | 1.82 | |
Inventory turnover | 0.7 | 0.76 | 0.81 | 0.92 | 0.99 | |
ROE | 0.13 | 0.1 | 0.1 | 0.1 | 0.11 | |
Capex per share | -0.06 | -0.05 | -0.06 | -0.06 | -0.07 |
MXIM Frequently Asked Questions
What is Maxim Integrated Products, Inc. stock symbol ?
Maxim Integrated Products, Inc. is a US stock , located in San jose of California and trading under the symbol MXIM
What is Maxim Integrated Products, Inc. stock quote today ?
Maxim Integrated Products, Inc. stock price is $103.14 today.
Is Maxim Integrated Products, Inc. stock public?
Yes, Maxim Integrated Products, Inc. is a publicly traded company.